AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine

NCT ID: NCT00351806

Last Updated: 2013-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-07-31

Study Completion Date

2006-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and to observe its safety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and safety.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Infarction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

acute intracerebral infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chinese herbal medicine

Group Type EXPERIMENTAL

Erigeron breviscapus injection

Intervention Type DRUG

hua tuo zai zao wan (a herbal medicine pill)

Intervention Type DRUG

Compound stroke herbal medicine (8 herbal)

Intervention Type DRUG

placebo

Group Type PLACEBO_COMPARATOR

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erigeron breviscapus injection

Intervention Type DRUG

hua tuo zai zao wan (a herbal medicine pill)

Intervention Type DRUG

Compound stroke herbal medicine (8 herbal)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ischemic stroke diagnosis by CT/MRI scan
* Yin pattern of Traditional Chinese Medicine Theory
* 40-85 years old
* Total anterior circulation infarcts (TACI), partial anterior territory cerebral infarction (PACI), lacunar anterior circulation infarcts (LACI) type under Oxfordshire Community Stroke Project (OCSP) standard
* NIHSS \>=4;
* Glasgow coma scale (GCS) \>=7;
* Modified Rankin Scale less than 2 degrees before onset of this stroke
* Informed consent signed by patient or his/her family

Exclusion Criteria

* Hemorrhagic stroke;
* Coma, GCS\<=7;
* Cerebral hernia;
* Serious heart, liver, lung, kidney functional failure;
* Gastrointestinal (GI) bleeding;
* Thrombolysis drugs or surgery was administrated to the patient;
* Not cooperative with physician;
* Psychological disorder;
* Already taken part in other clinical drug trial within the past 3 months
Minimum Eligible Age

40 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guangzhou University of Traditional Chinese Medicine

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Longhui Yang, Chairmam

Role: STUDY_CHAIR

Branch of Science and Education

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine

Beijing, Beijing Municipality, China

Site Status

Foshan Hospital of Traditional Chinese Medicine

Foshan, Guangdong, China

Site Status

2nd hospital of Zhongshan University

Guangzhou, Guangdong, China

Site Status

Neurology Center, Guangdong Province Hospital of Tradtional Chinese Medicine

Guangzhou, Guangdong, China

Site Status

Zhongshan Hospital of Traditional Chinese Medicine

Zhongshan, Guangdong, China

Site Status

Ruikang Hospital of Traditional Chinese Medicine

Nanning, Guangxi, China

Site Status

1st Hospital of Guangxi college of Traditional Chinese Medicine

Nanning, Guangxi, China

Site Status

The 1st Hospital of He'nan College of Traditional Chinese Medicine

Zhengzhou, Henan, China

Site Status

The teahing hospital of Hubei College of Traditional Chinese Medicine

Wuhan, Hubei, China

Site Status

Taizhou Hospital of Traditional Chinese Medicine

Taizhou, Jiangsu, China

Site Status

Jinan Hospital of Traditional Chinese Medicine

Jinan, Shandong, China

Site Status

Longhua Hospital of Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China

Site Status

Shanghai Hospital of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China

Site Status

Shuguang Hospital of Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China

Site Status

Yueyang Hospital of Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China

Site Status

zhongshan hospital of Fudan Unversity

Shanghai, Shanghai Municipality, China

Site Status

Huashan Hospital of Fudan Unveristy

Shanghai, Shanghai Municipality, China

Site Status

The Hosptial of Shanxi College of Traditional Chinese Medicine

Xian Yang, Shanxi, China

Site Status

The People's Hospital of Sichuan Province

Chengdu, Sichuan, China

Site Status

Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine

Ürümqi, Xinjiang, China

Site Status

Zhejiang Province Hospital of Traditional Chinese Medicine

Hangzhou, Zhejiang, China

Site Status

The 2nd Hospital of Wenzhou Medical College

Wenzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Huang Y, Guo JW; Project Group for Demonstration Study of Syndrome Differentiation Protocol and Effect Evaluation of Acute Ischemic Stroke. Outcome and safety assessment of an herbal medicine treatment protocol for yin pattern of acute ischemic stroke. Zhong Xi Yi Jie He Xue Bao. 2010 May;8(5):417-26. doi: 10.3736/jcim20100504.

Reference Type DERIVED
PMID: 20456839 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2004BA721A02

Identifier Type: -

Identifier Source: org_study_id